AMA Ed Hub Logo

Get fast-track DEA training from AMA Ed Hub™
Red JAMA Logo

Learn more on substance use disorders from JAMA Network™
2025 Annual Meeting of the HOD

Learn more on substance use disorders from PolicyFinder
Mature patient talking with psychotherapist in an office

Care for substance use disorder guide

Updated
| 3 Min Read
Clear Search
Doctor prescribing pharmacy to patient
·
4 Min Read

Cross DEA training requirement off your final-year residency checklist

Before you transition to practice, you must complete your MATE Act-required DEA training. An AMA Ed Hub course is tailored for your needs.

series
Transition to Attending
Transitioning to Practice

Membership Moves Medicine™

  • Thousands of free CME opportunities to fulfill state requirements
  • A powerful voice fighting for you during uncertain times
  • Research, resources, events and more from the largest physician organization
Join the AMA Today
Person colored with bright psychedelic paint
·
4 Min Read

Nonclinical psilocybin use soars. What should be done now?

A JAMA Psychiatry study shows a sharp increase in use of psilocybin mushrooms. Learn more, plus discover what interests you from across the JAMA Network.

Publications & Newsletters
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of Oct. 27, 2025

In the news: Stillbirths more common in U.S. than previously reported, GLP-1s show promise in treating substance use disorders and more. 

Publications & Newsletters
·
1 Min Read

Oct. 24, 2025: State Advocacy Update

New issue brief provides kratom and tianeptine basics, AMA recommendations, and more in the latest State Advocacy Update.

Advocacy Update
UPDATED
·
3 Min Read

Public health: CSAPH reports

Download PDFs of reports on this topic for the Council on Science and Public Health (CSAPH) presented during the AMA Interim and Annual Meetings.

Science & Public Health
Naloxone spray
·
5 Min Read

Naloxone can sustain our progress in fighting overdose deaths

Fatal drug overdoses fell 25% last year, sparking hope. Here are five practical steps we should take next to save lives.

series
Leadership
Leadership Viewpoints
Patient reads a prescription
·
3 Min Read

New FDA opioid labeling keep focus on individualized care

Agency action updates medication risk information and supports prescribing decisions tailored to individual patient needs. 

Behavioral Health
Person's hand embraces another's shoulders during a group discussion
·
5 Min Read

New tool brings mental health parity problems to light

The AMA collaborates on a tool to identify inequities in access, coverage and payment for mental health and substance-use services. 

Behavioral Health
·
1 Min Read

On opioid labeling, FDA emphasizes patient-physician relationship

The AMA commends the FDA for new label requirements for opioids that emphasizes shared decision-making between the patient and physician.

Press Releases